Anti-Infective Vaccines Market (Anti- Bacterial, Anti-Viral) Growing at a 5.88% CAGR by 2021
The Global Anti-Infective Vaccines Market (2016-2021) Report says rising incidences of typhoid, TB, hepatitis and other virus borne diseases will drive the market for anti-infective vaccines market. The report analyzed the market by Disease Type (Bacterial, Viral), Vaccine Type (Anti- Bacterial, Anti-Viral), Region and Country.
Pune, India – February 28, 2017 /MarketersMedia/ —
According to research report, “Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021)”, on account of rising incidences of typhoid, TB, hepatitis and Influenza among the growing population across the globe. North America region remains the major market followed by Europe in the actual period, while APAC and ROW region will witness strong growth in the forecast period.
Browse 98 Tables and Figures, 10 Companies, spread across 220 pages available at http://www.reportsnreports.com/reports/886397-global-anti-infective-vaccines-market-analysis-by-disease-type-bacterial-viral-by-region-by-country-opportunities-and-forecasts-2016-2021-by-vaccine-type-anti-bacterial-anti-viral-diseases-types-ia-china.html
Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand for anti-infective vaccines. Rising incidences of typhoid, TB, hepatitis and other virus borne diseases will drive the market for anti-infective vaccines market. Further, rising concerns over bioterrorism due to biological weapons along with increasing focus on the immunization programmes for prevention of diseases have been contributing in the growth of Anti Infective Vaccines.
Among the types of bacterial diseases, market is expected to be driven by typhoid and TB, mainly due to high number of cases in developing regions. However, antiviral vaccines will continue to generate major revenue due to increases R&D expenses along with rising number cases for various diseases like Influenza and ZIKA virus in developed regions. While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population along with escalating expenditure on immunization programmes by various NGO’s.
Order a Copy of Report @ http://www.reportsnreports.com/purchase.aspx?name=886397.
According to Latest research report, “Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021) – By Vaccine Type (Anti- Bacterial, Anti-Viral); Diseases-Types (TB, Typhoid, Influenza, Others), By Region (North America, Europe, APAC, ROW); By Country (USA, Canada, UK, France, India, China)”, Global Anti-Infective Vaccine market is projected to exhibit a CAGR of over ~5.88% during 2016 – 2021.
Check for Discount on this Report @ http://www.reportsnreports.com/contacts/discount.aspx?name=886397
Companies Mentioned
Teva Pharmaceutical Industries Ltd.
Emergent Biosolutions
Sanofi Pasteur, Inc.
GlaxoSmithKline
Merck & Co., Inc.
CSL Limited
Astrazeneca
Pfizer
Serum Institute Of India Pvt. Ltd.
Protein Sciences Corporation
List of Tables
Table 1: Typhoid Vaccines – Pipeline Products (Company and Stages)
Table 2: Tuberculosis Vaccines – Pipeline Products (Company and Stages)
Table 3: Tetanus and Diptheria Vaccines – Pipeline Products (Company and Stages)
List of Figures
Figure 1: Global Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 2: Global Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 3: Global Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 4: Global Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 5: Global Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 6: Global Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 7: Global Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 8: Global Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 9: Global Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 10: Global Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
And more.
About Us:
ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
Contact Info:
Name: Ritesh Tiwari
Email: sales@reportsandreports.com
Organization: ReportsnReports.com
Address: Magarpatta City, Pune, Maharashtra, India
Phone: +1-888-391-5441
For more information, please visit http://www.reportsnreports.com/reports/886397-global-anti-infective-vaccines-market-analysis-by-disease-type-bacterial-viral-by-region-by-country-opportunities-and-forecasts-2016-2021-by-vaccine-type-anti-bacterial-anti-viral-diseases-types-ia-china.html
Source: MarketersMedia
Release ID: 173436
Copyright © 1999-2013 SproutNews.com
